Linking comfort levels and knowledge gaps in hematology/oncology (HO) fellowship education: Insights from a multicenter survey.
Abstract
9030 Background: HO fellowship programs lack standardized educational approaches. This can impact learning & self-assessment of learning gaps. This study investigates the relationship between HO fellows’ (HOF) comfort levels & objective knowledge assessments across diverse HO topics, addressing a critical need for data in this area. Methods: HOF from 27 U.S. programs were invited to complete an anonymous survey (Sept-Oct 2023) in which they rated their comfort managing representative HO diseases, namely breast cancer (BC), plasma cell dyscrasias (PCD), hemophilia, von Willebrand disease (vWD), & heparin-induced thrombocytopenia (HIT), on a 7-point Likert scale (1 = extremely uncomfortable, 7 = extremely comfortable). An optional multiple choice knowledge quiz on these topics followed, including an option for “not sure & need to look it up.” Fellows were categorized into low (1–3), moderate (4–5), & high (6–7) comfort groups. One-way ANOVA assessed differences in knowledge scores by comfort levels. Results: In total,222 HOF completed the comfort survey (53% response rate): 82 PGY4 (37%), 72 PGY5 (32%), & 69 PGY6+ (31%). Also, 189 HOF completed the knowledge quiz (46% response rate): 71 PGY4 (38%), 57 PGY5 (30%), & 60 PGY6+ (31%). Mean comfort levels (±SD) were: BC diagnosis 4.8±1.4, localized BC management (mgmt.) 4.2±1.5, metastatic BC mgmt. 4.2±1.5, PCD diagnosis 4.8±1.4, MGUS/smoldering myeloma mgmt. 4.7±1.4, front-line myeloma treatment 4.5±1.6, maintenance myeloma treatment 4.1±1.5, inherited/acquired hemophilia mgmt. 3.7±1.5, vWD diagnosis 4±1.4, vWD mgmt. 3.8±1.4, HIT diagnosis 5.4±1.1, & HIT mgmt. 5.4±1.1. Mean knowledge scores were 41% for BC, 39% for PCD, 47% for hemophilia, 33% for vWD, & 51% for HIT. When evaluated by comfort level groups (low, medium, & high), knowledge scores increased significantly with higher comfort levels for BC (25%, 43%, 55%; p<0.01), PCD (25%, 38%, 51%; p<0.01), hemophilia (29%, 55%, 77%; p<0.01), & vWD (13%, 39%, 62%; p<0.01). HIT scores showed no significant difference by comfort levels (p=0.89). The number of “not sure” responses (%) significantly decreased (p<0.01) with greater comfort across topics: BC (53%, 20%, 10%), PCD (39%, 23%, 7%), hemophilia (52%, 28%, 2%), vWD (69%, 40%, 12%). HIT “not sure” responses showed no significant difference by comfort levels. Conclusions: This multicenter analysis demonstrates a correlation between HOF comfort levels & knowledge assessments. Despite overall low performance on knowledge tests, comfort levels effectively discriminated between knowledge groups, underscoring their potential utility as a surrogate for educational progress. These data highlight the need for interventions to bridge gaps between perceived & actual knowledge. Future studies to validate these results across broader topics & institutions to inform optimal education strategies in HO training programs are needed.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (19)
Ronak Mistry
2University of Pennsylvania Perelman School of Medicine, Division of Hematology/Oncology, Philadelphia, United States
Karine Tawagi
2University of Illinois Chicago, Chicago, United States
Samantha Ann Armstrong
Indiana University School of Medicine, Indianapolis, IN
Daniel Hausrath
2Vanderbilt University Medical Center, Nashville, United States
Inas Abuali
Mass General Brigham Cancer Institute, Boston, MA
Dillon Cockrell
Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC
Kayla Weiss Miranda
Baylor College of Medicine, Houston, TX
Ahmad M. Nassar
University of Illinois Chicago, Chicago, IL
Yurhee Lee
Olive View-UCLA Medical Center, Sylmar, CA
Victoria Chung
UT Southwestern Medical Center, Dallas, TX
Fadi Taza
Community Health MD Anderson Cancer Center, Indianapolis, IN
Matthew D Bloom
Thomas Jefferson University, Philadelphia, PA
Daniel Egert
Penn State Milton S. Hershey Medical Center, Hershey, PA
Giuliana Berardi
1Fox Chase Cancer Center, Hematology Oncology, Philadelphia, United States
Madeline Campbell Fitzpatrick
Dell Medical School, The University of Texas at Austin, Austin, TX
Aleena Itani
Texas Oncology, Flower-Mound, TX
Ericson Stoen
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC
Nathaniel R. Wilson
Emory University School of Medicine, Atlanta, GA
Vivek Patel